Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Carcinoma, Transitional Cell | Phase 1/Phase 2 | ClinicalTrials |
| Pancreatic Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Squamous Cell | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Colorectal Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Squamous Cell; Squamous Cell Carcinoma of Head and Neck | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Colorectal Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 1/Phase 2 | ClinicalTrials |
| Pancreatic Neoplasms | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS